TrialFind
Saved trials
Back to results
Completed
Phase 1
Phase 2
CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function
NCT01678794
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Mayo Clinic
Rochester, Minnesota, United States
View on ClinicalTrials.gov
Official details
CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function — TrialFind